INTRODUCTION
,5], CKD is and will remain a major global public health problem and the focus of detailed attention by healthcare professionals and policy makers [3 & ]. Patients with CKD often experience a high symptom burden which negatively impacts on their health-related quality of life (HRQOL) [6, 7] . Clinician-reported outcomes such as mortality rates, stage of kidney disease, and survival rates are established indicators of health [8] . However, it is increasingly acknowledged that clinician-reported outcomes do not adequately capture patients' HRQOL and underestimate their symptom burden [8, 9] . This may lead to a conflict of priorities between patients and clinicians, as aspects of HRQOL and symptoms that matter to patients may not be prioritized by the clinical team. HRQOL and/or symptoms can be measured from a patient perspective, without interpretation by anyone else, using self-administered, validated questionnaires also known as patient-reported outcome measures (PROMs) [10] . Therefore, the use of PROMs may complement clinician-reported outcomes by eliciting actionable information about patient HRQOL and/or symptoms and possibly assisting with the alignment of patient and clinician care priorities [11 && ]. Patient experience of care is now formally recognized as a crucial element of healthcare quality alongside patient safety and clinical effectiveness [12, 13] and its measurement can facilitate a patient-centred approach to evaluating healthcare quality [14 & ]. Patient experience of care may be objectively measured using patient-reported experience measures (PREMs). Figure 1 shows the interrelationships between elements of healthcare quality and measures of patient-reported outcomes and experience.
In this review, we present an overview of the use of PROMs/PREMs, and examine evidence from recent studies exploring the role of PROMs/PREMs in the measurement of quality of care specifically in CKD. We also summarize recent evidence of the use of PROMs/PREMs in other health conditions. Finally, we highlight key challenges and technological developments that may influence the use of PROMs and PREMs in future.
OVERVIEW OF PATIENT-REPORTED OUTCOME MEASURES AND PATIENT-REPORTED EXPERIENCE MEASURES
PROMs are increasingly used in research settings such as clinical trials, cohort studies, and prognostic modelling, to appraise the effectiveness and longterm safety of treatments from patients' perspective [10,15 & ]. A quick search of 'patient-reported outcome measures' on PubMed for the last 10 years, using the 'clinical trials' filter, yielded 1878 entriesalmost twice the number obtained for the previous decade; demonstrating the increasing use of these measures in clinical trials. On the other hand, the use of PROMs in routine clinical practice, and PREMs in all settings, is limited.
In clinical practice, aggregated PROM data are commonly used to audit and benchmark the performance of hospitals [16] . Since 2009, National Health Service (NHS) England has used PROMs to assess the quality of care delivered by NHS providers and quantify postoperative health gains from the patient perspective for surgical procedures comprising: total hip replacement, total knee replacement, varicose vein procedures, and groin hernia repairs [16] .
PROMs can also be used at an individual patient level in clinical practice to help to ensure that important aspects of health, that matter to patients, are brought to the attention of clinicians [14 & ]. Evidence suggests that this contemporary application of PROMs may improve patient-clinician communication [17] , and inform and promote shared decision-making [17] [18] [19] .
PREMs are designed to inquire about specific details of care and the actual occurrence of specific processes and/or events [20] rather than satisfaction with care. By adopting this approach, bias and subjectivity that arise from patients' expectations may be minimized [21, 22] .
PREMs assess a variety of domains including coordination of care, respect for patient preferences, and provision of medical information. Hospitals rated higher by patient experience questionnaires also perform better on clinical metrics [20, 23] . However, evidence of generalization of use is very limited; this is a shortfall as PREMs can benchmark
PATIENT-REPORTED OUTCOME MEASURES AND PATIENT-REPORTED EXPERIENCE MEASURES IN CHRONIC KIDNEY DISEASE
Patients with CKD require long-term care, the quality of which may have a significant impact on their HRQOL. PROMs/PREMs provide patients with an opportunity to describe the impact of disease and treatment on HRQOL, symptoms, and the quality of care they receive from their perspective.
Selection of measures: evidence from systematic reviews
There are numerous PROMs/PREMs available [25] . To ensure that appropriate measures are selected, it is vital that the purpose of measurement, the target population, the psychometric evidence supporting the measures under consideration, and the setting are carefully considered [26, 27] . Systematic reviews of PROMs/PREMs may provide psychometric evidence which may facilitate the selection process.
A [35] . See Table 1 for a description of all the PROMs referred to in this review.
A recent review by Beattie et al. [20] found evidence to support the use of a number of generic PREMs and recommended the use of the Hospital Consumer Assessment of Healthcare Providers and Systems [36] for purposes relating to research or financial remuneration; the Quality from the Patients' Perspective Shortened [37] to assess the effectiveness of quality improvement at a local level; and the Quality improvement in low-income settings [38] for low-income settings [20] . The Care Experience Feedback Improvement Tool is a new measure intended for quality improvement based on patient experience [39] . The majority of PREMs identified by Beattie et al. [20] were designed for use after discharge from hospital and varied widely in terms of purpose, the domains assessed, and timing of administration making it difficult to recommend any for use in CKD [20] . There is therefore a need to validate generic PREM tools in renal disease-specific settings or develop new tools that may be more relevant.
The validated renal-specific PREMs available are limited to dialysis and comprise:
(1) Consumer Assessment of Healthcare Providers and Systems In-Centre Haemodialysis Survey [40, 41] ; (2) Consumer Quality Index for chronic dialysis [42, 43] .
The validation of the UKRR National PREM survey was recently completed by the research team at University of Hertfordshire. Early reports of its psychometric properties are encouraging and the full report is due to be published shortly [44] . See Table 2 for a description of all the PREMs referred to in this review. These disease-specific instruments measure health in a way that is specific to a particular disease, set of conditions, or part of the body [27] .
Patient-reported outcome measures in chronic kidney disease clinical trials and research
KDQOL-36 A 36-item HRQOL measure designed for use in kidney disease patients undergoing dialysis. Derived from the KDQOL-SF [29] . There are three specific dimensions namely: (i) symptoms and problems (ii) burden of kidney disease (iii) effects of kidney disease It also includes two summary scales derived from the SF-12 namely: the physical (PCS) and mental (MCS) scales [30] . Overall scores range from 0 to 100 with higher scores indicating better HRQOL [29] .
KDQOL-SF
An 80-item HRQOL measure designed for use in kidney disease patients undergoing dialysis [31] . Derived from the 134-item KDQOL [31, 32] . Version 1.3 differs from version 1.2 by the addition of a screening question for sexual activity [31] . There are eight generic dimensions (from the SF-36) and eight disease-specific dimensions namely: (i) symptoms/problems (ii) effects of kidney disease on daily life (iii) burden of kidney disease (iv) work status (v) cognitive function (vi) quality of social interaction (vii) sexual function (viii) sleep There are three additional dimensions namely: (i) social support (ii) dialysis staff encouragement (ii) patient satisfaction Scores range from 0 to 100 for each dimension and higher scores indicate better HRQOL.
End-Stage Renal Disease Symptom
Checklist-Transplantation Module A 43-item symptom-specific QOL measure designed for use in renal transplant patients on immunosuppression therapy [33] . There are six dimensions: (i) limited physical capacity (ii) limited cognitive capacity (iii) cardiac and renal dysfunction (iv) side-effects of corticosteroids (v) increased growth of gum and hair (vi) transplantation-related psychological distress A 5-point Likert scale is used. Higher scores indicate worse QOL/symptoms [33] .
Modified ESAS
This is a measure of symptom burden for use in dialysis patients. It is a modification of the ESAS. There are 10 symptom-specific items and 10 visual analogue scales with superimposed 0-10 scale [34] . The scale for each symptom is anchored by the words 'No' and 'Severe' at 0 and 10, respectively and the sum of scores range from 0 to 100 with higher scores indicating greater symptom distress and burden [34] .
Integrated Patient Outcome ScaleRenal
A symptom-specific measure with 11 questions for use with patients with advanced kidney disease to assess their care needs. The questions relate to common symptoms renal patients experience and additional items such as information needs, practical issues, family anxiety [35] . The first question has a free text response format. Questions 2-9 have five response options whereas questions 10 and 11 have three response options each. The measure is currently being validated by researchers at the Department of Palliative Care, Policy and Rehabilitation at King's College London. Dimensions yet to be ascertained.
ESAS, Edmonton symptom assessment scale; HRQOL, health-related quality of life; KDQOL, kidney disease quality of life; KDQOL-SF, kidney disease quality of life short form; MCS, Mental Component Summary; PCS, Physical Component Summary; QOL, quality of life.
Assessment Scale, confirmed that the collection of ePROMs may be feasible and acceptable to patients in routine practice [49, 50] . Although emerging evidence of use of ePROM systems in a US oncology setting suggests that real-time monitoring and clinical response to ePROM data may reduce hospitalizations, improve HRQOL, and even improve survival [11 && ]. CPROR are currently undertaking feasibility and pilot work of a similar ePROM system.
Patient-reported outcome measures and patient-reported experience measures in renal registries
There are up to 144 renal registries worldwide [51] but their collection and use of PROM/PREM data are very limited. A review by Breckenridge et al. [43] reported that in Europe, only registries in Austria and France collected PROMs/PREMs [43] . In 2015, the UKRR, in partnership with NHS England, commenced the 'valuing individuals: transforming participation in CKD' programme to assess the feasibility and sustainability of routine collection of PROMs and PREMs from patients with CKD [44] . The UKRR, in conjunction with the British Kidney Patient Association, also developed a national strategy for an annual PREM survey to facilitate the benchmarking of kidney patient experience and inform service improvement for individual renal teams [52] .
CHALLENGES FOR PATIENT-REPORTED OUTCOME MEASURES AND PATIENT-REPORTED EXPERIENCE MEASURES IN CHRONIC KIDNEY DISEASE
Although there are clear benefits of using PROMs/ PREMs, there are also challenges associated with [36] .
Quality from the Patients' Perspective Shortened A 24-item measure with four domains: (i) medical/technical competence (ii) physical technical conditions (iii) identity-orientated approach (iv) sociocultural atmosphere [37] . Items are evaluated in two ways. The first method measures perceived reality of quality of care in all domains and a 4-point Likert scale is used except for the 'physical-technical conditions' domain. The 'physical-technical conditions' domain uses the response format is 'yes/no' format. The second method deals with the subjective importance given to various aspects of care and uses a 4-point response scale for all items [37] .
Quality improvement in low-income settings The successful implementation of PROMs/ PREMs requires a robust implementation strategy backed by strong and effective leadership [58] . Appropriate infrastructure relating to technological capability and data security need to be sorted out before the process is commenced [49, 50] . PROMs/ PREMs collection and utilization need to be integrated with existing clinical pathways and data collection methods to facilitate their adoption by clinicians [59] [60] [61] . There is a need for clear guidelines on how to effectively aggregate and incorporate patient-level PROM data into routine care in CKD [62, 63] .
For clinical trials, implementation strategies are required to ensure uniform administration of PROMs/PREMs across trial sites and address the current tendency for data collected with these measures to be compromized by high levels of missing data (a potential source of bias) [64] .
Clinician scepticism
Although the use of PROMs in clinical trials has increased significantly in the past few years [65] [66] have stressed the importance of clinician buy-in to ensure the success of any implementation plan [66] .
Interpretation and presentation of data
For PROMs/PREMs data to be of any value, it has to be accurately interpreted and translated into actionable information that can be used to inform and drive quality improvements within the healthcare system. After interpreting PROMs/PREMs data, the findings have to be presented in a format that will make sense to stakeholders and decision makers [63, 66] . It has been suggested that one of the reasons the NHS PROMs programme has had no appreciable impact to date may be because of the poor presentation quality of data [62] . Different approaches might be required when presenting PROM data to patients and clinicians [67] . A review by Bantug et al. [68 & ] reported that patients prefer simple line graphs and interpret them with the highest accuracy. Clinicians were found to prefer similar graphs but valued greater detail [68 & ,69] . There is an urgent need for more work needs to be done to establish standards for PROM data interpretation and presentation [67] .
THE FUTURE OF PATIENT-REPORTED OUTCOME MEASURES AND PATIENT-REPORTED EXPERIENCE MEASURES
At present, the most common method of collecting PROM/PREM data are by the administration of study-based questionnaires. However, this is changing rapidly as access to the internet improves and more people embrace the use of technological innovations such as smartphones, tablet devices, and mobile phone applications [49, 70] . The ePROM system currently developed by researchers at CPROR and University Hospitals Birmingham NHS Foundation Trust may assist with the remote monitoring of symptom deterioration between scheduled clinic appointments and provide clinicians the opportunity to intervene promptly. It may also encourage patients to become more engaged with their care and potentially facilitate shared decision-making between patients and clinicians, an integral principle of patient-centred care [14 & ]. Computer adaptive testing (CAT) is an algorithm-based method of PROM administration whereby the most relevant items (questions) from an item bank are automatically selected and administered sequentially, based on a respondent's prior responses with the aim of maximizing the information obtained about the respondent [71 & ]. Using a CAT simulation of the WHO Quality of Life-100 questionnaire, Gibbons et al. [71 & ] recently demonstrated that electronic item banks could provide accurate measurements that are significantly shorter and often more reliable than paper-based versions [71 researchers and clinicians to deploy cloud-based CATs directly to patients via the internet and mobile phone applications [72] .
Current technological innovations may also assist with the integration of PROM data with other routinely collected electronic health data such as laboratory test results. These integrated data also referred to as 'Big Data' have the potential to facilitate the delivery of high-quality care that is 'personal and tailored' to individual patients, development of diagnostic algorithms, and enhanced clinical audit [73, 74] .
CONCLUSION
The drive for improvement in quality of renal care requires the adoption of a patient-centred approach to the provision of renal care and the measurement of its quality for significant progress to be achieved. Health providers need to design and properly implement robust strategies, which put the patient at the heart of service provision. This requires effective leadership and significant cultural and organizational changes.
The use of PREMs and PROMs may facilitate this process by giving patients the avenue to provide actionable information about their health and encouraging shared decision-making between patients and their healthcare providers/clinicians. Recent advances in technology could lead to PROMs/ PREMs playing a significant role in transforming healthcare delivery in future. The Health Foundation is an independent charity committed to bringing about better health and healthcare for people in the UK. The Health Foundation was not involved in any other aspect of the review.
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